The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis

Cunwei Liu, Lei Wang, Ping Wang, Di Xiao, Qinghua ZouInternational Journal of Molecular Sciences 2023 · DOI

TL;DR

This study uncovers key genetic and proteomic mechanisms behind tigecycline resistance in Acinetobacter baumannii, a critical multi-drug resistant pathogen. The research highlights the crucial role of efflux pumps, driven by genomic changes like the disruption of the hns and acrR genes, in conferring resistance, offering insights for combating challenging infections.

What Problem Does This Paper Address?

Acinetobacter baumannii is a notorious hospital-acquired pathogen, notorious for its resistance to a wide array of antibiotics. As a last-resort antibiotic, tigecycline is vital for treating infections caused by these multi-drug resistant strains. However, the emergence of tigecycline resistance in A. baumannii poses a significant threat, and the underlying mechanisms have remained largely elusive. This paper aims to elucidate these mechanisms by comparing tigecycline-resistant and susceptible strains, bridging the gap in our understanding of how this critical antibiotic fails.

Methods

The researchers employed a multi-pronged approach combining proteomic and genomic analyses.

  • Strain Selection: They generated tigecycline-resistant strains from susceptible ones through sub-inhibitory concentrations of tigecycline and high-temperature selection. Conversely, they also derived tigecycline-susceptible strains from resistant ones.
  • Proteomics: iTRAQ (isobaric tags for relative and absolute quantitation) labeling followed by LC-MS/MS (Liquid Chromatography-Mass Spectrometry/Mass Spectrometry) was used to identify and quantify differentially expressed proteins between resistant and susceptible strains. This allowed them to pinpoint proteins whose abundance changed with tigecycline resistance.
  • Genomics: Third-generation whole genome sequencing (Illumina Hiseq and PacBio RSII) was performed to identify genetic variations, including single nucleotide variations (SNVs), insertions, deletions, and large-scale rearrangements, between the selected strains.
  • Specific Gene Analysis: Techniques like PCR were used to confirm the presence and disruption of specific genes, such as hns and acrR.
  • Functional Assays: Efflux pump inhibition experiments using PAẞN and CCCP were conducted to assess the role of efflux pumps in resistance. Complementation experiments were also performed to restore gene function and observe the effect on tigecycline susceptibility.

Datasets

The study utilized two pairs of Acinetobacter baumannii strains:

  1. 17978S (tigecycline-susceptible parent) and 17978R (tigecycline-resistant derivative).
  2. A54R (tigecycline-resistant parent) and A54S (tigecycline-susceptible derivative).

The whole genome sequencing data was deposited in GenBank (accession number PRJNA850273), and the proteomics data was deposited in ProteomeXchange (accession number PXD034784). No new benchmarks were introduced; the study focused on analyzing existing strains and their variations.

Key Insights and Ideas

  • Efflux Pumps are Central: The study strongly implicates efflux pumps as the primary drivers of tigecycline resistance. Proteins associated with these pumps were consistently upregulated in resistant strains.
  • Genomic Rearrangements Drive Resistance: The research uncovers specific genomic alterations that lead to increased efflux pump activity. This includes the loss of plasmids carrying the hns gene and the disruption of hns and acrR genes by IS5 insertion.
  • H-NS as a Negative Regulator: The global negative regulator hns appears to play a critical role. Its loss or disruption leads to increased expression of genes involved in iron acquisition and potentially efflux pumps via TonB.
  • AcrR's Repressive Role: The disruption of acrR, a known repressor of the AcrAB efflux pump system, directly contributes to increased efflux pump activity and thus tigecycline resistance.
  • Complexity Beyond Efflux: While efflux pumps are key, the study acknowledges that other mechanisms, such as changes in biofilm formation and iron acquisition, also contribute to the overall resistance phenotype.
  • Plasmid Loss as an Adaptation Strategy: The loss of large plasmids in resistant strains, even without direct antibiotic resistance genes, suggests a broader adaptation strategy where the bacteria shed non-essential genetic material to conserve energy and focus on survival under stress.

Key Results

  • Proteomic Upregulation: Proteins involved in efflux pumps, biofilm formation, iron acquisition, stress response, and metabolic processes were significantly upregulated in tigecycline-resistant strains (17978R and A54R).
  • Efflux Pump Inhibition: Using efflux pump inhibitors (PAẞN and CCCP) reduced the Minimum Inhibitory Concentration (MIC) of tigecycline for the resistant strain 17978R by 2-8 fold, confirming the role of efflux pumps, though not fully restoring susceptibility.
  • Genomic Variations:
    • Loss of large plasmids was observed in the selected resistant strains (17978R and A54S).
  • Disruption of the hns gene by IS5 insertion was identified in 17978R.
  • Disruption of the acrR gene by IS5 insertion, leading to the deletion of 15 genes, was found in 17978R.
  • Single nucleotide variations were identified in both resistant strains, with one affecting a SAM-dependent methyltransferase (ACX60_03215) previously linked to tigecycline resistance.
  • H-NS Deletion Impact: Deleting the hns gene in A. baumannii increased tigecycline resistance (MIC from 0.5 µg/mL to 1 µg/mL), supporting its role as a negative regulator.
  • AcrR Complementation: Complementation of the acrR gene in the resistant strain 17978R reduced its tigecycline MIC from 128 ng/µL to 64 ng/µL.

Limitations and Future Work

  • Complexity of Resistance: The authors acknowledge that tigecycline resistance is complex and not solely attributable to efflux pumps, even though they are the primary mechanism.
  • Incomplete Reversal: Efflux pump inhibitors did not fully restore tigecycline susceptibility, indicating the involvement of other resistance mechanisms.
  • Random IS Insertion: While the IS5 insertion into hns was confirmed to be random, further investigation into the precise conditions and frequency of such events under sub-MIC tigecycline pressure could be valuable.
  • Biofilm Formation Role: The relationship between increased biofilm formation in 17978R and tigecycline resistance is speculative and warrants further experimental validation.
  • Future Directions: The study suggests that understanding these genomic and proteomic mechanisms will be crucial for developing strategies to combat multi-drug resistant A. baumannii infections. Further research could focus on targeting these specific resistance pathways or developing novel therapeutic approaches.

Summary updated

Abstract

The mechanism of tigecycline resistance in <i>A. baumannii</i> remains largely unclear. In this study, we selected a tigecycline-resistant and a tigecycline-susceptible strain from a tigecycline-susceptible and a resistant strain, respectively. Proteomic and genomic analyses were performed to elucidate the variations associated with tigecycline resistance. Our study showed proteins associated with efflux pump, biofilm formation, iron acquisition, stress response, and metabolic ability are upregulated in tigecycline resistant strains, and efflux pump should be the key mechanism for tigecycline resistance. By genomic analysis, we found several changes in the genome that can explain the increased level of efflux pump, including the loss of the global negative regulator <i>hns</i> in the plasmid and the disruption of the <i>hns</i> gene and <i>acrR</i> gene on the chromosome by the insertion of IS5. Collectively, we not only revealed the phenomenon that the efflux pump is mainly responsible for tigecycline resistance, but also highlighted the mechanism at the genomic level, which will help in understanding the resistance mechanism in detail and provide clues for the treatment of clinical multiple drug-resistant <i>A. baumannii</i>.
BibTeX
@article{liu2023mechanism,
  author = {Cunwei Liu and Lei Wang and Ping Wang and Di Xiao and Qinghua Zou},
  title = {{The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis}},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24108652},
}
Figure